Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Esteve

Showing results (281-290 of 285) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 285 results.
Blood Cancer Journal|October 3, 2015
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patientsJ Bladé, J F San Miguel, M Fontanillas, et al.
British Journal of Haematology|July 27, 2001
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA groupM González, E Barragán, P Bolufer, et al.
Journal of Hematology & Oncology|July 26, 2018
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemiaE Genescà, A Lazarenkov, M Morgades, et al.
Leukemia|June 30, 2020
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDSA Kuendgen, M Nomdedeu, H Tuechler, et al.
Pageof 29

Showing results (281-290 of 285) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 285 results.
Blood Cancer Journal|October 3, 2015
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patientsJ Bladé, J F San Miguel, M Fontanillas, et al.
British Journal of Haematology|July 27, 2001
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA groupM González, E Barragán, P Bolufer, et al.
Journal of Hematology & Oncology|July 26, 2018
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemiaE Genescà, A Lazarenkov, M Morgades, et al.
Leukemia|June 30, 2020
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDSA Kuendgen, M Nomdedeu, H Tuechler, et al.
Pageof 29